CAS 33887-02-4

Clonazolam

Description:

Clonazolam is a synthetic benzodiazepine derivative that is primarily known for its anxiolytic, sedative, and muscle relaxant properties. It belongs to the class of compounds that act on the central nervous system by enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA). Clonazolam is characterized by its high potency and relatively long duration of action compared to other benzodiazepines. It typically appears as a white to off-white crystalline powder and is often encountered in research settings or as a designer drug. The substance is not approved for medical use in many countries, and its safety profile is not well-established, leading to potential risks of dependence, overdose, and adverse effects. Due to its psychoactive properties, clonazolam is subject to legal restrictions in various jurisdictions, and its use should be approached with caution. As with all benzodiazepines, it is important to consider the potential for tolerance and withdrawal symptoms with prolonged use.

Formula: C₁₇H₁₂ClN₅O₂

InChI: InChI=1S/C17H12ClN5O2/c1-10-20-21-16-9-19-17(12-4-2-3-5-14(12)18)13-8-11(23(24)25)6-7-15(13)22(10)16/h2-8H,9H2,1H3

InChI key: InChIKey=XJRGLCAWBRZUFC-UHFFFAOYSA-N

SMILES: N(=O)(=O)C=1C=C2C(N3C(CN=C2C4=C(Cl)C=CC=C4)=NN=C3C)=CC1

Synonyms:

• 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 6-(2-chlorophenyl)-1-methyl-8-nitro-
• 6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
• 4H-s-Triazolo[4,3-a][1,4]benzodiazepine, 6-(o-chlorophenyl)-1-methyl-8-nitro-
• 1-Methyl-6-(o-chlorophenyl)-8-nitro-4H-s-triazolo[4,3-a][1,4]benzodiazepine
• 8-Nitro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine

Clonazolam, 1mg/ml acetonitrile solution

Controlled Product

CAS: 33887-02-4

Clonazolam (CRM) is a medicinal compound that acts as a protein kinase inhibitor. It has been shown to have anticancer properties and induce apoptosis in tumor cells, making it a potential treatment for cancer. CRM is an analog of the well-known benzodiazepine Clonazepam and is excreted in human urine. It has been tested on Chinese hamster ovary cells and shown to inhibit kinases involved in cancer cell growth. The use of CRM as an anticancer agent is still being studied, but its potential as a targeted therapy for certain types of cancer is promising.

Formula: C₁₇H₁₂ClN₅O₂

Purity: Min. 95%

Color and Shape: Clear Liquid

Molecular weight: 353.8 g/mol

Ref: 3D-IBA88702

8-Nitro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine

Controlled Product

CAS: 33887-02-4

Formula: C₁₇H₁₂ClN₅O₂

Color and Shape: Neat

Molecular weight: 353.762

Ref: TR-N495945